News & Events

Weekly Media Tip Sheet

FDA News & Notes – Week of July 25, 2016

Science, public health, and regulatory highlights from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as of July 25, 2016. Times listed are local time.

FDA News & Notes does not contain any regulatory or enforcement actions due to legal limitations.

Meetings, Workshops and Congressional Testimony:
 
Tuesday, 7/26 – The Cellular, Tissue, and Gene Therapies Advisory Committee will meet by teleconference for updates on research programs in the Laboratory of Molecular Oncology and the Laboratory of Biological Chemistry, Division of Biotechnology Review and Research I and IV, Office of Biotechnology Products (OBP), CDER, FDA. The meeting will take place beginning at 1 p.m. on the FDA’s White Oak Campus, Silver Spring, Md. For those unable to attend in person, there will be a live webcast of the meeting.
Press Office Contact: Andrea Fischer, 301-796-0393, andrea.fischer@fda.hhs.gov
 
On the Web:
 
Registration is now open – Public Workshop; Scientific Evidence in the Development of Human Cells, Tissues, and Cellular and Tissue-Based Products Subject to Premarket Approval. The FDA has announced a public workshop, “Scientific Evidence in the Development of Human Cells, Tissues, and Cellular and Tissue-Based Products Subject to Premarket Approval.” The workshop will take place on Sept. 8, 2016, at 8:30 a.m. on the FDA’s White Oak Campus, Silver Spring, Md.
Press Office Contact: Andrea Fischer, 301-796-0393, andrea.fischer@fda.hhs.gov
 
In Case You Missed It:
     
Thursday, 7/21 – FDA Voice Blog: Practical Applications of FDA Regulations for the Indian Food Industry. Globalization of the food supply chain and advances in food processing technologies have led American consumers to develop a taste for a variety of foods and cuisines from different countries. Increasingly, U.S. grocery stores sell foods from Asia, Latin America, and many other parts of the world. Indian exporters have recognized this marketing opportunity, and FDA data show an increase in U.S. imports from India over the past 10 years. A wealth of ready-to-eat Indian specialties can be found in cans and bottles on U.S. store shelves including Indian curries (gravies), canned sweets, pickled cucumbers, and Indian pickles (chopped fruits and vegetables marinated in brine).
Press Office Contact: FDA Office of Media Affairs, 301-796-4540, fdaoma@fda.hhs.gov
 
Tuesday, 7/19 – News Release: Federal court orders Minnesota sprout and noodle company to cease operations due to unsanitary conditions. On July 15, 2016, the U.S. District Court for the District of Minnesota entered a consent decree of permanent injunction between the United States and Kwong Tung Foods, Inc., doing business as Canton Foods; its president and owner, Vieta “Victor” C. Wang; and its vice-president, Juney H. Wang, for significant and ongoing violations of the Federal Food, Drug, and Cosmetic Act and its implementing regulations. The business, located in Minneapolis, Minn., sells rice and wheat noodles, and mung bean and soy bean sprouts.
Press Office Contact: Fallon Smith, 301-796-8632, fallon.smith@fda.hhs.gov
 
Tuesday, 7/19 – FDA Voice Blog: Addressing Global Challenges through Transatlantic Cooperation. On a recent trip to Brussels, our FDA delegation met with many of our European Union regulatory counterparts and stakeholders to discuss ways to strengthen our shared commitment to product safety and public health. Reflecting the broad scope of our transatlantic dialogue, we engaged on an array of issues, including supply chain safety, quality metrics, risk-based surveillance, data integrity, mutual reliance, and food safety systems.
Press Office Contact: FDA Office of Media Affairs, 301-796-4540, fdaoma@fda.hhs.gov
 
Monday, 7/18 – FDA Voice Blog: The Rise in Orphan Drug Designations: Meeting the Growing Demand. Developing drugs for rare diseases, once considered a rare phenomenon itself, has fast become a mainstay for many companies’ drug development pipelines. This is exciting news for the 30 million Americans with rare diseases and their families. 
Press Office Contact: FDA Office of Media Affairs, 301-796-4540, fdaoma@fda.hhs.gov   
      
 

FDA Office of Media Affairs Contact Information:

FDA News & Notes Inquiries: Fallon Smith, 301-796-8632, fallon.smith@fda.hhs.gov
General Inquiries: Call or e-mail FDA Office of Media Affairs, 301-796-4540, fdaoma@fda.hhs.gov
List of FDA Press Officers and beats

More Resources:

Read our Blog: FDA Voice
FDA Photosdisclaimer icon (Flickr)
Consumer Health Information

Page Last Updated: 07/25/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.